Diagnosis, Care, and Specialist Access for Patients Across India
Sorsby fundus dystrophy is a rare inherited macular condition that Indian retina specialists recognise as behaving somewhat differently from other macular dystrophies — it tends to progress faster, typically becoming symptomatic in a patient's 40s or 50s, and carries a strong tendency toward abnormal blood vessel growth beneath the retina.
Because it's genuinely rare, most Indian ophthalmologists will encounter only a handful of cases over an entire career, which means patients are often referred to a retina sub-specialist with specific experience in inherited macular conditions once the diagnosis is suspected.
Night vision difficulty is often an early complaint, sometimes noticed years before central vision changes become obvious — a detail Indian patients sometimes dismiss as simply getting older. As the condition progresses, central vision blur and distortion become more prominent, often accelerated by episodes of abnormal blood vessel growth that can cause a relatively sudden drop in vision, in contrast to the slower decline typical of several other macular dystrophies.
The condition is caused by mutations in the TIMP3 gene, inherited in an autosomal dominant pattern, meaning each child of an affected Indian parent has roughly a 50% chance of inheriting the mutation. TIMP3 normally helps regulate a membrane layer in the eye called Bruch's membrane; when it malfunctions, this membrane thickens abnormally and appears to encourage the abnormal blood vessel growth that drives much of the condition's faster typical progression.
Diagnosis relies on detailed retinal imaging — OCT and fundus photography to identify the characteristic yellowish deposits, and OCT angiography or fluorescein angiography to map any active abnormal blood vessel growth, both increasingly available at India's major retina centres. Genetic testing for TIMP3, offered by a handful of specialised Indian labs, confirms the diagnosis and can identify at-risk relatives before symptoms begin.
Anti-VEGF injection therapy — the same treatment class used for wet age-related macular degeneration and now well established across Indian retina practice — is the primary tool for managing episodes of abnormal blood vessel growth in Sorsby fundus dystrophy. Given the condition's faster typical pace, Indian specialists often recommend closer monitoring intervals than for some other macular dystrophies, to catch new episodes early.
It's genuinely rare — most Indian ophthalmologists see very few cases over their careers, which is why referral to a retina specialist experienced in inherited macular conditions is often recommended once it's suspected.
A limited number of specialised Indian diagnostic labs now offer TIMP3 testing, though it may require coordination with a tertiary retina centre familiar with the condition.
Because it typically becomes symptomatic later in life — the 40s or 50s — and early night vision symptoms are sometimes mistaken for normal ageing, delaying the eventual eye exam that leads to diagnosis.
Coverage varies significantly between insurers and specific policies in India; it's worth checking directly with your insurance provider and treating hospital, since anti-VEGF therapy costs and coverage differ considerably from routine eye care.